These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18596226)

  • 1. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
    Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
    Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
    Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
    Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.
    Iclozan C; Yu Y; Liu C; Liang Y; Yi T; Anasetti C; Yu XZ
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):170-8. PubMed ID: 19804837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice.
    Pan B; Zhang Y; Sun Y; Cheng H; Wu Y; Song G; Chen W; Zeng L; Xu K
    Cytokine; 2014 Aug; 68(2):69-75. PubMed ID: 24845795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
    Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.
    Sun K; Hsiao HH; Li M; Ames E; Bouchlaka M; Welniak LA; Hagino T; Jagdeo J; Pai CC; Chen M; Blazar BR; Abedi M; Murphy WJ
    J Immunol; 2012 Aug; 189(4):2033-42. PubMed ID: 22778394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function.
    Fu J; Wang D; Yu Y; Heinrichs J; Wu Y; Schutt S; Kaosaard K; Liu C; Haarberg K; Bastian D; McDonald DG; Anasetti C; Yu XZ
    J Immunol; 2015 Jan; 194(1):388-97. PubMed ID: 25404360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
    Fujiwara H; Maeda Y; Kobayashi K; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Chen L; Azuma M; Yagita H; Tanimoto M
    J Immunol; 2014 Sep; 193(5):2565-73. PubMed ID: 25080485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
    J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.
    Carlson MJ; West ML; Coghill JM; Panoskaltsis-Mortari A; Blazar BR; Serody JS
    Blood; 2009 Feb; 113(6):1365-74. PubMed ID: 18957685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
    Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
    Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
    Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.
    Ma Q; Li D; Nurieva R; Patenia R; Bassett R; Cao W; Alekseev AM; He H; Molldrem JJ; Kroll MH; Champlin RE; Sale GE; Afshar-Kharghan V
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1174-81. PubMed ID: 22664751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An absence of donor TH17 differentiation ameliorates dermal tissue damage].
    Cheng H; Song GL; Pan B; Tian J; Yan ZL; Chen W; Xu KL; Li ZY; Zeng LY
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1843-6. PubMed ID: 22093788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptively transferred donor IL-17-producing CD4
    Cai Y; Ma S; Liu Y; Gong H; Cheng Q; Hu B; Wu Y; Yu X; Dong C; Sun K; Wu D; Liu H
    Cell Mol Immunol; 2018 Mar; 15(3):233-245. PubMed ID: 27748733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 contributes to CD4-mediated graft-versus-host disease.
    Kappel LW; Goldberg GL; King CG; Suh DY; Smith OM; Ligh C; Holland AM; Grubin J; Mark NM; Liu C; Iwakura Y; Heller G; van den Brink MR
    Blood; 2009 Jan; 113(4):945-52. PubMed ID: 18931341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role for donor-derived IL-22 in cutaneous chronic GVHD.
    Gartlan KH; Bommiasamy H; Paz K; Wilkinson AN; Owen M; Reichenbach DK; Banovic T; Wehner K; Buchanan F; Varelias A; Kuns RD; Chang K; Fedoriw Y; Shea T; Coghill J; Zaiken M; Plank MW; Foster PS; Clouston AD; Blazar BR; Serody JS; Hill GR
    Am J Transplant; 2018 Apr; 18(4):810-820. PubMed ID: 28941323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
    Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
    Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice.
    Shi Y; Liu XF; Zhuang Y; Zhang JY; Liu T; Yin Z; Wu C; Mao XH; Jia KR; Wang FJ; Guo H; Flavell RA; Zhao Z; Liu KY; Xiao B; Guo Y; Zhang WJ; Zhou WY; Guo G; Zou QM
    J Immunol; 2010 May; 184(9):5121-9. PubMed ID: 20351183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Inflammatory T Helper Cells
    Buchele V; Abendroth B; Büttner-Herold M; Vogler T; Rothamer J; Ghimire S; Ullrich E; Holler E; Neurath MF; Hildner K
    Front Immunol; 2018; 9():1138. PubMed ID: 29910804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.